Terms: = Endocrine gland cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Clinical Outcome
5 results:
1. Baseline immunity predicts prognosis of pancreatic cancer patients treated with wt1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy.
Ota S; Miyashita M; Yamagishi Y; Ogasawara M
Hum Vaccin Immunother; 2021 Dec; 17(12):5563-5572. PubMed ID: 34919493
[TBL] [Abstract] [Full Text] [Related]
2. Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center phase I/II trial.
Ogasawara M; Miyashita M; Yamagishi Y; Ota S
Ther Apher Dial; 2021 Aug; 25(4):415-424. PubMed ID: 33886156
[TBL] [Abstract] [Full Text] [Related]
3. Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma.
Hollis RL; Stanley B; Iida Y; Thomson J; Churchman M; Rye T; Mackean M; Nussey F; Gourley C; Herrington CS
Gynecol Oncol; 2019 Nov; 155(2):318-323. PubMed ID: 31495455
[TBL] [Abstract] [Full Text] [Related]
4. Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
Parra-Herran C; Lerner-Ellis J; Xu B; Khalouei S; Bassiouny D; Cesari M; Ismiil N; Nofech-Mozes S
Mod Pathol; 2017 Dec; 30(12):1748-1759. PubMed ID: 28776572
[TBL] [Abstract] [Full Text] [Related]
5. Immunophenotype and human papillomavirus status of serous adenocarcinoma of the uterine cervix.
Togami S; Sasajima Y; Kasamatsu T; Oda-Otomo R; Okada S; Ishikawa M; Ikeda S; Kato T; Tsuda H
Pathol Oncol Res; 2015 Apr; 21(2):487-94. PubMed ID: 25370301
[TBL] [Abstract] [Full Text] [Related]